Veracyte (VCYT) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
23 Apr, 2026Executive summary
Annual Meeting scheduled for June 10, 2026, to be held virtually for shareholder participation.
Shareholders are encouraged to review proxy materials and vote by June 9, 2026.
Voting matters and shareholder proposals
Election of nine directors to serve until the 2027 Annual Meeting or until successors are elected.
Ratification of Ernst & Young LLP as independent registered public accounting firm for 2026.
Advisory approval of executive compensation (say-on-pay) for named executive officers.
Approval of an amendment to the 2023 Equity Incentive Plan.
Proxies may vote on other business arising at the meeting or any adjournment.
Board of directors and corporate governance
Nine nominees are recommended for election to the board, including Eliav Barr, Muna Bhanji, Karin Eastham, Robert S. Epstein, Jens Holstein, Evan Jones, Tom Miller, Brent Shafer, and Marc Stapley.
Latest events from Veracyte
- All agenda items passed, with directors elected and equity plan amended; no questions raised.VCYT
AGM 202610 Jun 2026 - Double-digit growth, new launches, and strong margins drive an optimistic outlook.VCYT
Jefferies Global Healthcare Conference 20264 Jun 2026 - Prosigna and TrueMRD launches and raised 2026 guidance highlight strong momentum.VCYT
46th Annual William Blair Growth Stock Conference4 Jun 2026 - OPTIMA and ENZAMET trials confirm Prosigna and Decipher guide safe, effective cancer therapy.VCYT
Study update1 Jun 2026 - Revenue up 21% and net income up 307% year-over-year, with raised 2026 guidance.VCYT
Q1 20266 May 2026 - Proxy covers director elections, auditor ratification, compensation, and equity plan changes.VCYT
Proxy filing23 Apr 2026 - Double-digit revenue and profit growth in 2025, with strong 2026 outlook and new launches ahead.VCYT
Q4 202513 Apr 2026 - Decipher and Afirma drive growth as Prosigna and MRD launches set the stage for future expansion.VCYT
Leerink Global Healthcare Conference 20269 Mar 2026 - Strong 2025 growth, new launches, and global expansion drive double-digit gains in 2026.VCYT
47th Annual Raymond James Institutional Investor Conference3 Mar 2026